Bayer developed and sponsored a laminated pain-management teaching tool that incorporates ADA’s recommendation of considering nonsteroidal anti-inflammatory drugs as first-line therapy for the management of acute pain.The reference, Non-Opioid Management of Acute Dental Extraction Pain, is included as an insert in the Sept. 21 print edition of ADA News.
There is broad consensus, the two-sided tool explains, that NSAID medications either alone or coupled with acetaminophen have been demonstrated to be an effective approach to pain management without having to resort to opioids.
Prescription opioids can be prescribed by dentists to treat moderate to severe pain, but can also have serious risks and side effects.
Along with sponsoring the insert, Bayer is also distributing the ADA Dental Drug Handbook book and e-book to all third- and fourth-year dental students at American dental schools during the 2020-21 school year. About 13,000 students will receive the handbook.
In addition, Bayer is sponsoring the Practice Update Clinical Dentistry Channel for 10 months. The ADA and Elsevier added a dental category in 2020 to Practice Update, a free online resource exclusively designed for health care professionals.